AlphaFold predicted structure
MCCC1 · Q96RQ3

Mean pLDDT
87.6/ 100
Confident
725 residues
Confidence breakdown
- Very high(≥ 90)68%
- Confident(70–90)23%
- Low(50–70)2%
- Very low(< 50)8%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
methylcrotonyl-CoA carboxylase subunit 1
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomalChildhood onset dystonia, chorea or related movement disorder
Fetal anomalies
BIALLELIC, autosomal or pseudoautosomalHyperammonaemia
Isolated 3-methylcrotonyl-CoA carboxylase deficiency
3-methylcrotonyl-CoA carboxylase deficiency
hereditary disease
Parkinson disease
neurodegenerative disease
Lewy body dementia
retinitis pigmentosa
Progressive cone dystrophy
Cone rod dystrophy
early-onset non-syndromic cataract
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial
Biotin-attachment subunit of the 3-methylcrotonyl-CoA carboxylase, an enzyme that catalyzes the conversion of 3-methylcrotonyl-CoA to 3-methylglutaconyl-CoA, a critical step for leucine and isovaleric acid catabolism
MCCC1 · Q96RQ3

Mean pLDDT
87.6/ 100
Confident
725 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0